Deerfield Management’s Kite Pharma, Inc. KITE Stock Holding History

Deerfield Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-81,000	Closed	-$6.36M	–	110
2017 Q1	$6.36M	Sell	81,000 -216,902	-73%	-$13.4M	0.25%	83
2016 Q4	$13.4M	Buy	+297,902	New	+$14.6M	0.55%	56
2015 Q1	–	Sell	-155,799	Closed	-$8.98M	–	141
2014 Q4	$8.98M	Sell	155,799 -856,199	-85%	-$36M	0.32%	64
2014 Q3	$28.8M	Buy	+1,011,998	New	+$25M	1.05%	31

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Deerfield Management's KITE Position: Q2 2017 in Review

Deerfield Management sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 81,000 shares — an estimated $6.36M sold.

Deerfield Management first reported a position in KITE in Q3 2014 and held it in 4 quarters. The position peaked at $28.8M in Q3 2014. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

Deerfield Management reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
Deerfield Management sold 81,000 Kite Pharma, Inc. shares in Q2 2017, an estimated $6.36M.
Deerfield Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 4 quarters.
Deerfield Management's Kite Pharma, Inc. position peaked at $28.8M in Q3 2014.
220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on Deerfield Management's 13F filing for Q2 2017, filed 14 Aug 2017.